Author:
Edlin Richard,Hall Peter,Wallner Klemens,McCabe Christopher
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference18 articles.
1. Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions;Walker;Value Health,2012
2. Department of Health, Medicines, Pharmacy & Industry Group. A new value based approach to the pricing of branded medicines: government response to consultation. 2011. Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_128404.pdf. [Accessed April 16, 2014].
3. Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems;Stafinski;Pharmacoeconomics,2010
4. Access with evidence development schemes: a framework for description and evaluation;McCabe;Pharmacoeconomics,2010
5. Value based pricing for NHS drugs: an opportunity not to be missed?;Claxton;BMJ,2008
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献